Menu

Star on GitHub · 3.2k

CVE-2011-3386

4.0 · MEDIUM

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (a…

Published Sep 2, 2011medtronicEPSS 1.45%

Overview

CVE-2011-3386 is a medium-severity vulnerability affecting medtronic paradigm_wireless_insulin_pump. It was published on September 2, 2011 and has a CVSS 2.0 base score of 4.0 (MEDIUM).

This vulnerability has a CVSS 2.0 base score of 4.0, rated MEDIUM. It can be exploited remotely over the network. No authentication or special privileges are required for exploitation.

Technical description

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."

Remediation

Check the references section for vendor advisories and patches from medtronic. Update paradigm_wireless_insulin_pump to the latest patched version. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Affected products

VendorProductVersionsStatus

Frequently asked questions

What is CVE-2011-3386?

CVE-2011-3386 is a medium-severity vulnerability affecting medtronic paradigm_wireless_insulin_pump. It was published on September 2, 2011 and has a CVSS 2.0 base score of 4.0 (MEDIUM).

How severe is CVE-2011-3386?

This vulnerability has a CVSS 2.0 base score of 4.0, rated MEDIUM. It can be exploited remotely over the network. No authentication or special privileges are required for exploitation.

How do I fix or remediate CVE-2011-3386?

Check the references section for vendor advisories and patches from medtronic. Update paradigm_wireless_insulin_pump to the latest patched version. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2011-3386?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2011-3386 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.

Related MEDIUM CVEs from 2011

View all